Presentation is loading. Please wait.

Presentation is loading. Please wait.

The PPAR-α agonist GW7647 reduces experimentally induced myopia.

Published byありあ みおか Modified over 5 years ago

Similar presentations

Presentation on theme: "The PPAR-α agonist GW7647 reduces experimentally induced myopia."— Presentation transcript:

1 The PPAR-α agonist GW7647 reduces experimentally induced myopia.
The PPAR-α agonist GW7647 reduces experimentally induced myopia. The effect of 63- and 189-μg intravitreal injections of GW7647 on the ocular axial length of LIM animals is shown: both the 63-μg (n = 8) and 189-μg injections (n = 8) of GW7647 significantly reduce myopia as compared with control (n = 7). * indicates that a group is significantly different from the controls with p < 0.05 using Student’s t test. Eric Bertrand et al. Mol Cell Proteomics 2006;5: © 2006 The American Society for Biochemistry and Molecular Biology

Download ppt "The PPAR-α agonist GW7647 reduces experimentally induced myopia."

Similar presentations

14-3-3 binding sites 58 of the 473 unambiguously assigned phosphorylation sites are predicted by Scansite to be sites for 14-3-3 binding. 50 of these correspond.

binding sites 58 of the 473 unambiguously assigned phosphorylation sites are predicted by Scansite to be sites for binding. 50 of these correspond.
Correlation of log-transformed signal intensity from two Affymetrix microarray hybridizations using platelet RNA. Plotted are those probesets with an average.

Correlation of log-transformed signal intensity from two Affymetrix microarray hybridizations using platelet RNA. Plotted are those probesets with an average.
Sequence alignment of C-terminal phosphorylated plant aquaporins

Sequence alignment of C-terminal phosphorylated plant aquaporins
Distribution of phosphorylation sites identified in the cytosolic phosphoproteome.A, numbers of approved phosphopeptides, previously phosphorylated peptides,

Distribution of phosphorylation sites identified in the cytosolic phosphoproteome.A, numbers of approved phosphopeptides, previously phosphorylated peptides,
Percentage of proteins identified in envelope membrane extracts according to the purification method and the number of transmembrane domains. Percentage.

Percentage of proteins identified in envelope membrane extracts according to the purification method and the number of transmembrane domains. Percentage.
Plasma CEP adducts and autoantibodies by donor age.

Plasma CEP adducts and autoantibodies by donor age.
Illustration of matched (FL-IFN-γR2/GFP and IFN-γR1/EBFP) and mismatched (IFN-γR1/EBFP and FL-IL-10R2/GFP) pairs of receptors. Illustration of matched.

Illustration of matched (FL-IFN-γR2/GFP and IFN-γR1/EBFP) and mismatched (IFN-γR1/EBFP and FL-IL-10R2/GFP) pairs of receptors. Illustration of matched.
Frequency distribution of the GRAVY of the theoretical proteins (open bars) and of 110 genes encoding proteins identified on a 2-D electrophoresis gel,

Frequency distribution of the GRAVY of the theoretical proteins (open bars) and of 110 genes encoding proteins identified on a 2-D electrophoresis gel,
Improvement of insulin sensitivity by treatment of the annexin A1 receptor agonist in HFD mice. Improvement of insulin sensitivity by treatment of the.

Improvement of insulin sensitivity by treatment of the annexin A1 receptor agonist in HFD mice. Improvement of insulin sensitivity by treatment of the.
Distributions of the ELDP values and Mascot scores for all protein identifications.a, frequency of ELDP value returned by correct (gray bars) and incorrect.

Distributions of the ELDP values and Mascot scores for all protein identifications.a, frequency of ELDP value returned by correct (gray bars) and incorrect.
Significantly enriched phosphorylation motifs from up-regulated phosphopeptides by Motif-X analysis. Significantly enriched phosphorylation motifs from.

Significantly enriched phosphorylation motifs from up-regulated phosphopeptides by Motif-X analysis. Significantly enriched phosphorylation motifs from.
Visual validation of the computational outputs.

Visual validation of the computational outputs.
Novel p53 target genes identified by RNA-Seq, pSILAC and ChIP-Seq.

Novel p53 target genes identified by RNA-Seq, pSILAC and ChIP-Seq.
Assay of NOS activity. Assay of NOS activity. Box show total NOS activity, the calcium-dependent activity of the constitutive isoforms of NOS (eNOS and.

Assay of NOS activity. Assay of NOS activity. Box show total NOS activity, the calcium-dependent activity of the constitutive isoforms of NOS (eNOS and.
Relative abundance of proteins identified in MALDI IMS

Relative abundance of proteins identified in MALDI IMS
Comparison of ROC plots for the PMF quality metrics using test dataset 2 (44 C. difficile proteins).a, ROC curves for coverage (open squares), MC (solid.

Comparison of ROC plots for the PMF quality metrics using test dataset 2 (44 C. difficile proteins).a, ROC curves for coverage (open squares), MC (solid.
Success rates in validation of antibodies from external providers

Success rates in validation of antibodies from external providers
Results from the Morris water task.

Results from the Morris water task.
Degree of glycosylation of human milk LF from individual donors across lactation. Degree of glycosylation of human milk LF from individual donors across.

Degree of glycosylation of human milk LF from individual donors across lactation. Degree of glycosylation of human milk LF from individual donors across.
Correction of translational start site by identification of N-terminal peptide. Correction of translational start site by identification of N-terminal.

Correction of translational start site by identification of N-terminal peptide. Correction of translational start site by identification of N-terminal.

Similar presentations

Ads by Google